These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12181072

  • 1. Reversal of coumarin-induced over-anticoagulation.
    Escobar MA.
    Br J Haematol; 2002 Sep; 118(3):925-6; author reply 926. PubMed ID: 12181072
    [No Abstract] [Full Text] [Related]

  • 2. Fondaparinux reversal with activated prothrombin complex concentrate in anesthetised bleeding rats.
    Corbonnois G, Martin M, Hacquard M, Levy B, Mertes PM, Lecompte T, Audibert G.
    Thromb Haemost; 2013 Mar; 109(3):560-3. PubMed ID: 23306598
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reversal of a potent investigational anticoagulant: idraparinux with recombinant factor VIIa.
    Dao A, Tuan B, Carlson N.
    Am J Med; 2005 Oct; 118(10):1172-3. PubMed ID: 16194652
    [No Abstract] [Full Text] [Related]

  • 5. What is the evidence for the off-label use of recombinant factor VIIa (rFVIIa) in the acute reversal of warfarin? ASH evidence-based review 2008.
    Rosovsky RP, Crowther MA.
    Hematology Am Soc Hematol Educ Program; 2008 Oct; ():36-8. PubMed ID: 19074054
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recombinant factor VIIa use following massive pulmonary hemorrhage after CPB.
    Courtney H.
    Paediatr Anaesth; 2009 Mar; 19(3):272. PubMed ID: 19236650
    [No Abstract] [Full Text] [Related]

  • 8. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA, Johnson NB, Case J, Warden B, Hughes D, Zimmerman J, Roberti G, McMillian WD, Schreiber M.
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [Abstract] [Full Text] [Related]

  • 9. Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.
    Frumkin K.
    Ann Emerg Med; 2013 Dec; 62(6):616-626.e8. PubMed ID: 23829955
    [Abstract] [Full Text] [Related]

  • 10. Treatment of acute bleeding with recombinant factor VIIa in a patient with IgA deficit receiving anticoagulant therapy.
    Sanchis Cervera J, Andrés Blasco CJ, Mena-Duran AV.
    Acta Haematol; 2003 Dec; 110(1):51-2. PubMed ID: 12975561
    [No Abstract] [Full Text] [Related]

  • 11. Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage.
    Rowe AS, Turner RM.
    Am J Health Syst Pharm; 2010 Mar 01; 67(5):361-5. PubMed ID: 20172985
    [Abstract] [Full Text] [Related]

  • 12. Recombinant activated factor VII as a temporary reversal agent for warfarin anticoagulation: a cautionary report on an off-label application.
    Kalainov DM, Valentino LA.
    Am J Orthop (Belle Mead NJ); 2008 Nov 01; 37(11):572-4. PubMed ID: 19104685
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel oral anticoagulants: new challenges for anesthesiologists in bleeding patients.
    Spahn DR, Korte W.
    Anesthesiology; 2012 Jan 01; 116(1):9-11. PubMed ID: 21993157
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant factor VIIa for refractory hemorrhage after lung transplantation.
    Cimic N, Tulleken JE, Zijlstra JG, van der Bij W, Boonstra PW.
    Transplantation; 2005 Mar 27; 79(6):741-2. PubMed ID: 15785389
    [No Abstract] [Full Text] [Related]

  • 18. Traumatic haemorrhage: a role for recombinant factor VIIa?
    Spivey MH, Duffy MR.
    Anaesthesia; 2009 Oct 27; 64(10):1141-2. PubMed ID: 19735409
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Does the use of recombinant factor VIIA reduce morbidity or mortality in nonhemophiliac patients?
    Sattler S, Schwartz A.
    Ann Emerg Med; 2012 Aug 27; 60(2):160-1. PubMed ID: 22542308
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.